• On sale!
search

NEOBOROCILLINA ANT OR * 16PAS AR

  • Alfasigma S.p.A.
  • 004901219
Neo Borocillina Oropharyngeal Antiseptic is a drug based on the active ingredient benzyl alcohol + sodium benzoate - belonging to the category of Antiseptics and specifically Antiseptics. Neo Borocillina Oropharyngeal Antiseptic can be prescribed with OTC Recipe - self-medication. Antiseptic of the oropharyngeal cavity (throat - mouth and gums).
info_outline View product sheet
Final Price €8.90

Volume discounts

Quantity Unit discount You Save
2 10% €1.78
5 15% €6.68
10 25% €22.25
Quantity
check_circle Available
Shipped within 24 h
  Convenient and safe payments

Even with a credit card

  Shipping in 24h all over the world

Fast and safe international shipping worldwide

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service. Experts in international shipping

Other products Others products at unbeatable price

Alfasigma S.p.A.

Discover all products

NEOBOROCILLINA ANT OR * 16PAS AR

Therapeutic indications

Antiseptic of the oropharyngeal cavity (throat, mouth and gums).

Dosage and method of use

In adults: slowly dissolve one tablet in the mouth every 2/3 hours up to a maximum of 8 tablets per day. In children aged 6 to 10 years: slowly dissolve one tablet in the mouth every 5/6 hours up to a maximum of 4 tablets per day. To keep the mucous membrane under the action of the medicine for as long as possible, the tablets should be allowed to dissolve slowly in the mouth. Do not exceed the recommended dose.

Contraindications

Known individual hypersensitivity to components or strictly correlated substances from a chemical point of view.

Side effects

The components are well tolerated substances and therefore the administration ofNeo Borocillin Oropharyngeal Antisepticit usually has no side effects.Reporting of suspected adverse reactions.Reporting of suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit / risk ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse

Special warnings

The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. In this case it is necessary to interrupt the treatment and consult the doctor in order to establish any suitable therapy. This medicine contains 6.4 mg benzyl alcohol per tablet as an active ingredient. Benzyl alcohol can cause allergic reactions. Large volumes should be used with caution and only if necessary, especially in patients with hepatic or renal insufficiency and in pregnant or lactating women due to the risk of accumulation and toxicity (metabolic acidosis). This medicinal product contains 52 mg of sodium benzoate per tablet as the active ingredient corresponding to 8.3 mg of sodium (main component of table salt) per tablet and 66.4 mg of sodium per daily dose equivalent to 3.3% of the intake. maximum daily recommended by the WHO which corresponds to 2 g of sodium for an adult. Neo Borocillin Oropharyngeal Antiseptic 6.4 mg + 52 mg menthol eucalyptol flavor tablets contains 1224 mg of glucose and 1494.02 of sucrose per tablet. Neo Borocillin Oropharyngeal Antiseptic 6.4 mg + 52 mgHoney lemon flavored tablets contains 1208.35 mg of glucose and 1475.88 of sucrose per tablet.Neo Borocillin Oropharyngeal Antiseptic 6.4 mg + 52 mgOrange flavored tablets contains 1205.11 mg of glucose and 1471.91 of sucrose per tablet. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. To be taken into consideration in people with diabetes mellitus. After a short treatment period of no more than 10 days, with no appreciable results, consult your doctor. KEEP THE MEDICINAL PRODUCT OUT OF THE REACH AND SIGHT OF CHILDREN.

Pregnancy and breastfeeding

In pregnant women, the product should be administered in case of real need and under direct medical supervision.

Expiration and retention

Store at a temperature not exceeding 30 ° C.

Interactions with other drugs

None known.

Overdose

There are no known symptoms of overdose.

Active principles

Atabletcontains: - Benzyl alcohol 6.4 mg; - Sodium benzoate 52 mg (equivalent to 44.1 mg of benzoic acid). Excipient with known effects:menthol-eucalyptol flavor tabletsSucrose 1494.02 mg, Glucose 1224 mg.lemon honey flavored tabletsSucrose 1475.88 mg; Glucose 1208.35 mg.orange flavored tabletsSucrose 1471.91 mg; Glucose 1205.11 mg. For the full list of excipients, see 6.1.

Excipients

Menthol eucalyptol flavor tablets:sucrose,glucose, mint essence, Levomentol, Cineol, Indigo carmine (E 132), Curcumin extract (E 100).Honey lemon flavored tablets:sucrose, glucose, Lemon flavor, Citrus flavor, Honey flavor, Levomentol.Orange flavored tablets:sucrose, glucose, Orange flavor, Citrus flavor, Levomentol.

004901219

Data sheet

Packaging
6 -4 mg + 56 mg 16 orange flavored tablets
6,4 mg + 56 mg 16 pastiglie gusto arancia
Product Type
HUMAN DRUG
ATC code
R02AA20
ATC description
Various
Therapeutic Group
Antiseptics
Active principle
benzyl alcohol + sodium benzoate
Class
C.
Pharmaceutical form
candy pastille
Type of Administration
buccal / mucoadhesive
Container
candy / pads
Quantity
16 candies / tablets
Quantity of the Active Ingredient
6 -4MG (benzyl alcohol) + 52MG (sodium benzoate)
6,4MG (alcool benzilico) + 52MG (sodio benzoato)
Recipe required
OTC - self-medication medicine
chat Comments (0)
Fast Order